Home › Therapeutic areas › Neurology › Myasthenia Gravis
Myasthenia Gravis (4 companies)
Companies with an active program in Myasthenia Gravis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| CABA | Cabaletta Bio, Inc. | DermatologyImmunologyNeurologyRenal Rare | 1 | Phase 1 | 8 |
| IMVT | Immunovant, Inc. | ImmunologyNeurology Rare | 1 | Phase 2 | 6 |
| KYTX | Kyverna Therapeutics, Inc. | ImmunologyNeurologyRenal Rare | 1 | NDA Submitted | 7 |
| VOR | Vor Biopharma Inc. | ImmunologyNeurologyOncology Rare | 1 | Phase 3 | 4 |
No companies match.